JPS5798275A - Benzodiazepine derivatives - Google Patents

Benzodiazepine derivatives

Info

Publication number
JPS5798275A
JPS5798275A JP56118571A JP11857181A JPS5798275A JP S5798275 A JPS5798275 A JP S5798275A JP 56118571 A JP56118571 A JP 56118571A JP 11857181 A JP11857181 A JP 11857181A JP S5798275 A JPS5798275 A JP S5798275A
Authority
JP
Japan
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56118571A
Other languages
English (en)
Inventor
Buranka Kiriko
Edouaruto Fuitsushiy Aruberuto
Sutsuente Andore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5798275A publication Critical patent/JPS5798275A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP56118571A 1980-07-31 1981-07-30 Benzodiazepine derivatives Pending JPS5798275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH584280 1980-07-31

Publications (1)

Publication Number Publication Date
JPS5798275A true JPS5798275A (en) 1982-06-18

Family

ID=4300206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56118571A Pending JPS5798275A (en) 1980-07-31 1981-07-30 Benzodiazepine derivatives

Country Status (10)

Country Link
US (1) US4377522A (ja)
EP (1) EP0045451A3 (ja)
JP (1) JPS5798275A (ja)
AU (1) AU550032B2 (ja)
CA (1) CA1163266A (ja)
DK (1) DK341281A (ja)
IL (1) IL63405A0 (ja)
NZ (1) NZ197825A (ja)
PH (1) PH18271A (ja)
ZA (1) ZA815114B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132295A1 (ja) * 2005-06-09 2006-12-14 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤
JP2008516975A (ja) * 2004-10-19 2008-05-22 スミスクライン ビーチャム コーポレーション 化合物
US7381005B2 (en) 2003-06-30 2008-06-03 The Procter And Gamble Company Pressurized dispensing package and method for using the same

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ES2190428T3 (es) * 1991-06-28 2003-08-01 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogeno.
US6403578B1 (en) 1993-12-21 2002-06-11 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
ES2725928T3 (es) 2014-06-20 2019-09-30 Constellation Pharmaceuticals Inc Formas cristalinas de 2-((4S)-6-(4-clorofenil)-1-metil-4H-benzo[c]isoxazolo[4,5-e]azepin-4-il)acetamida
CN114605331A (zh) * 2022-03-17 2022-06-10 上海健康医学院 一种尼鲁米特及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429874A (en) * 1966-12-22 1969-02-25 Schering Corp 1-polyhalogenoalkyl-2-oxo-1,3-dihydro-2h-1,4-benzodiazepines
CH562220A5 (ja) * 1969-02-14 1975-05-30 Hoffmann La Roche
US4155904A (en) * 1973-02-08 1979-05-22 Schering Corporation Process for the preparation of 1,4-benzo-diazepines and 1,4-benzodiazepinones
CA1114373A (en) * 1978-08-11 1981-12-15 Albert E. Fischli Benzodiazepine derivatives
US4251443A (en) * 1979-08-02 1981-02-17 Hoffmann-La Roche Inc. Benzodiazepine derivatives
CA1145333A (en) * 1980-02-08 1983-04-26 Quirico Branca Benzodiazepine derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381005B2 (en) 2003-06-30 2008-06-03 The Procter And Gamble Company Pressurized dispensing package and method for using the same
JP2008516975A (ja) * 2004-10-19 2008-05-22 スミスクライン ビーチャム コーポレーション 化合物
WO2006132295A1 (ja) * 2005-06-09 2006-12-14 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤

Also Published As

Publication number Publication date
ZA815114B (en) 1982-08-25
US4377522A (en) 1983-03-22
IL63405A0 (en) 1981-10-30
EP0045451A2 (de) 1982-02-10
AU7339681A (en) 1982-02-04
DK341281A (da) 1982-02-01
PH18271A (en) 1985-05-14
CA1163266A (en) 1984-03-06
NZ197825A (en) 1985-07-31
EP0045451A3 (de) 1985-10-02
AU550032B2 (en) 1986-02-27

Similar Documents

Publication Publication Date Title
GB2079270B (en) Imidazo-rifamycin derivatives
HK17586A (en) N-arylbenzamide derivatives
GB2086380B (en) L-argininal derivatives
JPS5798275A (en) Benzodiazepine derivatives
ZA815115B (en) Benzodiazepine derivatives
ZA81695B (en) Benzodiazepine derivatives
GB2083462B (en) 2-thiopenem derivatives
GB2067989B (en) Bis-moranoline derivatives
GB2075499B (en) Nonaprenylamine derivatives
ZA81694B (en) Benzodiazepine derivatives
GB8324990D0 (en) 3-aminopropoxyphenyl derivatives
GB2088379B (en) 1-phenethylimidazole derivatives
GB2085882B (en) Aprosamine derivatives
GB2076815B (en) Aminophenylpyridine derivatives
GB2070589B (en) 7a1methoxycephalospin derivatives
GB2076395B (en) Nonaprenylamine derivatives
GB2074165B (en) Nonaprenylamine derivatives
ZA815327B (en) Benzazepine derivatives
GB2073201B (en) Steroid-spiro-oxathiazolidine derivatives
ZA813051B (en) Benzodiazepine derivatives
ZA815357B (en) Benzazepine derivatives
ZA815193B (en) Benzazepine derivatives
GB2069998B (en) Benzenethiocarbamate derivatives
IE802217L (en) Guanidine-thiazolyl-nitropyrrole derivatives
IE800919L (en) Benzimidiazole derivatives